• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌疲劳:心力衰竭的机械能量学概念。

Myocardial Fatigue: a Mechano-energetic Concept in Heart Failure.

机构信息

Department of Cardiology, University Hospitals Coventry & Warwickshire, Coventry, CV2 2DX, UK.

Centre for Sport, Exercise & Life Sciences, Faculty of Health and Life Sciences, Alison Gingell Building, Coventry University, Coventry, CV1 2DS, UK.

出版信息

Curr Cardiol Rep. 2022 Jun;24(6):711-730. doi: 10.1007/s11886-022-01689-2. Epub 2022 Mar 30.

DOI:10.1007/s11886-022-01689-2
PMID:35353328
Abstract

PURPOSE OF REVIEW

This review combines existing mechano-energetic principles to provide a refreshing perspective in heart failure (HF) and examine if the phenomenon of myocardial fatigue can be rigorously tested in vitro with current technological advances as a bridge between pre-clinical science and clinical practice.

RECENT FINDINGS

As a testament to the changing paradigm of HF pathophysiology, there has been a shift of focus from structural to functional causes, as reflected in its modern universal definition and redefined classification. Bolstered by recent landmark trials of sodium-glucose cotransport-2 inhibitors across the HF spectrum, there is a rekindled interest to revisit the basic physiological tenets of energetic efficiency, metabolic flexibility, and mechanical load on myocardial performance. Indeed, these principles are well established in the study of skeletal muscle fatigue. Since both striated muscles share similar sarcomeric building blocks, is it possible that myocardial fatigue can occur in the face of sustained adverse supra-physiological load as a functional cause of HF? Myocardial fatigue is a mechano-energetic concept that offers a novel functional mechanism in HF. It is supported by current studies on exercise-induced cardiac fatigue and reverse translational science such as from recent landmark trials on sodium glucose co-transporter 2 inhibitors in HF. We propose a novel framework of myocardial fatigue, injury, and damage that aligns with the contemporary notion of HF as a continuous spectrum, helps determine the chance and trajectory of myocardial recovery, and aims to unify the plethora of cellular and molecular mechanisms in HF.

摘要

目的综述

本文综合现有的机械能量学原理,为心力衰竭(HF)提供新视角,并探讨心肌疲劳现象能否在体外通过当前技术进步进行严格测试,从而在临床前科学和临床实践之间架起桥梁。

最近的发现

随着 HF 病理生理学范式的转变,人们的关注点已经从结构性原因转移到功能性原因,这反映在其现代通用定义和重新定义的分类中。最近 HF 谱中钠-葡萄糖共转运蛋白 2 抑制剂的里程碑式试验进一步证实了这一点,人们重新燃起了兴趣,重新审视能量效率、代谢灵活性和机械负荷对心肌性能的基本生理原理。事实上,这些原理在骨骼肌疲劳研究中已得到充分证实。由于横纹肌具有相似的肌节结构,那么在面对持续的超生理负荷时,心肌是否会出现疲劳,这是否是 HF 的一种功能性原因?心肌疲劳是一种机械能量学概念,为 HF 提供了一种新的功能性机制。它得到了关于运动诱导性心肌疲劳的现有研究以及反向转化科学的支持,如最近 HF 中钠葡萄糖共转运蛋白 2 抑制剂的里程碑式试验。我们提出了一种新的心肌疲劳、损伤和损伤框架,与 HF 作为连续谱的现代概念一致,有助于确定心肌恢复的机会和轨迹,并旨在统一 HF 中众多的细胞和分子机制。

相似文献

1
Myocardial Fatigue: a Mechano-energetic Concept in Heart Failure.心肌疲劳:心力衰竭的机械能量学概念。
Curr Cardiol Rep. 2022 Jun;24(6):711-730. doi: 10.1007/s11886-022-01689-2. Epub 2022 Mar 30.
2
Myocardial Fatigue at a Glance.心肌疲劳一览。
Curr Heart Fail Rep. 2023 Jun;20(3):191-193. doi: 10.1007/s11897-023-00603-3. Epub 2023 May 3.
3
Treatments for skeletal muscle abnormalities in heart failure: sodium-glucose transporter 2 and ketone bodies.心力衰竭中骨骼肌异常的治疗方法:钠-葡萄糖共转运体 2 和酮体。
Am J Physiol Heart Circ Physiol. 2022 Feb 1;322(2):H117-H128. doi: 10.1152/ajpheart.00100.2021. Epub 2021 Dec 3.
4
Cardio-renal benefits of sodium-glucose co-transporter 2 inhibitors in heart failure with reduced ejection fraction: mechanisms and clinical evidence.钠-葡萄糖协同转运蛋白2抑制剂对射血分数降低的心力衰竭患者的心肾益处:作用机制与临床证据
Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):311-321. doi: 10.1093/ehjcvp/pvab056.
5
Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.酮体代谢改变及治疗性酮症在心力衰竭中的意义。
Circulation. 2020 Jun 2;141(22):1800-1812. doi: 10.1161/CIRCULATIONAHA.119.045033. Epub 2020 Jun 1.
6
Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.心肌代谢活跃和氧化应激:让我们在心力衰竭的斗争中与它们成为朋友。
Biomed Pharmacother. 2010 Mar;64(3):203-7. doi: 10.1016/j.biopha.2009.10.002. Epub 2009 Nov 13.
7
Role of sodium glucose co-transporter 2 inhibitors in patients with heart failure: an elusive mechanism.钠-葡萄糖共转运蛋白 2 抑制剂在心力衰竭患者中的作用:一个难以捉摸的机制。
Ann Med. 2020 Aug;52(5):178-190. doi: 10.1080/07853890.2020.1767298. Epub 2020 May 22.
8
Empagliflozin directly improves diastolic function in human heart failure.恩格列净直接改善人类心力衰竭患者的舒张功能。
Eur J Heart Fail. 2018 Dec;20(12):1690-1700. doi: 10.1002/ejhf.1328. Epub 2018 Oct 17.
9
Myocardial metabolism in heart failure: Purinergic signalling and other metabolic concepts.心力衰竭中心肌代谢:嘌呤能信号转导和其他代谢概念。
Pharmacol Ther. 2019 Feb;194:132-144. doi: 10.1016/j.pharmthera.2018.08.015. Epub 2018 Aug 25.
10
Prevention of heart failure events with sodium-glucose co-transporter 2 inhibitors across a spectrum of cardio-renal-metabolic risk.钠-葡萄糖共转运蛋白 2 抑制剂预防各种心肾代谢风险的心力衰竭事件。
Eur J Heart Fail. 2021 Jun;23(6):1002-1008. doi: 10.1002/ejhf.2135. Epub 2021 Mar 8.

引用本文的文献

1
Heterogeneity of Fatigue in Patients with Chronic Heart Failure: Latent Categories and Influencing Factors.慢性心力衰竭患者疲劳的异质性:潜在类别与影响因素
Int J Gen Med. 2025 Feb 19;18:857-866. doi: 10.2147/IJGM.S522314. eCollection 2025.
2
Proteoglycans in Mechanobiology of Tissues and Organs: Normal Functions and Mechanopathology.组织和器官力学生物学中的蛋白聚糖:正常功能与机械病理学
Proteoglycan Res. 2024 Apr-Jun;2(2). doi: 10.1002/pgr2.21. Epub 2024 May 20.
3
Inversion of Left Ventricular Axial Shortening: In Silico Proof of Concept for Treatment of HFpEF.

本文引用的文献

1
Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes.肌肉因子与心力衰竭:在不良心脏重构、心肌病和临床结局方面的挑战性作用。
Dis Markers. 2021 Jan 13;2021:6644631. doi: 10.1155/2021/6644631. eCollection 2021.
2
Myocardial Tissue Reverse Remodeling After Guideline-Directed Medical Therapy in Idiopathic Dilated Cardiomyopathy.特发性扩张型心肌病患者接受指南指导的药物治疗后的心肌组织逆向重构。
Circ Heart Fail. 2021 Jan;14(1):e007944. doi: 10.1161/CIRCHEARTFAILURE.120.007944. Epub 2020 Nov 13.
3
An Analysis of Myocardial Efficiency in Patients with Severe Asymptomatic Mitral Regurgitation.
左心室轴向缩短反转:射血分数保留的心力衰竭治疗的计算机概念验证
Bioengineering (Basel). 2024 Jul 2;11(7):676. doi: 10.3390/bioengineering11070676.
4
The Stiffness of the Ascending Aorta Has a Direct Impact on Left Ventricular Function: An In Silico Model.升主动脉僵硬度对左心室功能有直接影响:一项计算机模拟模型研究
Bioengineering (Basel). 2024 Jun 12;11(6):603. doi: 10.3390/bioengineering11060603.
5
Rising arterial stiffness with accumulating comorbidities associates with heart failure with preserved ejection fraction.随着共病的积累,动脉僵硬度的增加与射血分数保留的心力衰竭有关。
ESC Heart Fail. 2023 Aug;10(4):2487-2498. doi: 10.1002/ehf2.14422. Epub 2023 Jun 6.
6
Profiling the Biomechanical Responses to Workload on the Human Myocyte to Explore the Concept of Myocardial Fatigue and Reversibility: Rationale and Design of the POWER Heart Failure Study.分析人类心肌细胞对工作负荷的生物力学反应,探索心肌疲劳和可逆性概念:POWER 心力衰竭研究的原理和设计。
J Cardiovasc Transl Res. 2024 Apr;17(2):275-286. doi: 10.1007/s12265-023-10391-9. Epub 2023 May 1.
7
Myocardial inefficiency is an early indicator of exercise-induced myocardial fatigue.心肌效率低下是运动诱发心肌疲劳的早期指标。
Front Cardiovasc Med. 2023 Jan 11;9:1081664. doi: 10.3389/fcvm.2022.1081664. eCollection 2022.
8
Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance.胰岛素刺激心肌葡萄糖代谢率受损与不同程度葡萄糖耐量受试者的估计心肌能量效率降低有关。
Cardiovasc Diabetol. 2023 Jan 9;22(1):4. doi: 10.1186/s12933-022-01733-z.
9
Developing a contemporary community clinic for patients with heart failure with preserved ejection fraction within the current National Health Service model.在当前的国民保健制度模式下,为射血分数保留的心力衰竭患者开发一个现代化的社区诊所。
Open Heart. 2022 Nov;9(2). doi: 10.1136/openhrt-2022-002101.
10
The Effects of Device-Based Cardiac Contractility Modulation Therapy on Left Ventricle Global Longitudinal Strain and Myocardial Mechano-Energetic Efficiency in Patients with Heart Failure with Reduced Ejection Fraction.基于设备的心脏收缩力调制疗法对射血分数降低的心力衰竭患者左心室整体纵向应变和心肌机械能效率的影响。
J Clin Med. 2022 Oct 4;11(19):5866. doi: 10.3390/jcm11195866.
重度无症状二尖瓣反流患者心肌效率分析
J Cardiovasc Imaging. 2020 Oct;28(4):267-278. doi: 10.4250/jcvi.2020.0038.
4
Heart Failure in Humans Reduces Contractile Force in Myocardium From Both Ventricles.人类心力衰竭会降低两个心室心肌的收缩力。
JACC Basic Transl Sci. 2020 Jul 22;5(8):786-798. doi: 10.1016/j.jacbts.2020.05.014. eCollection 2020 Aug.
5
Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?达格列净用于射血分数保留的心力衰竭:DELIVER研究能否带来成果?
Diabetes Ther. 2020 Oct;11(10):2207-2219. doi: 10.1007/s13300-020-00911-0. Epub 2020 Aug 27.
6
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂心血管获益机制:最新综述
JACC Basic Transl Sci. 2020 Jun 22;5(6):632-644. doi: 10.1016/j.jacbts.2020.02.004. eCollection 2020 Jun.
7
Regulation of Myofilament Contractile Function in Human Donor and Failing Hearts.人类供体心脏和衰竭心脏中肌丝收缩功能的调节
Front Physiol. 2020 May 25;11:468. doi: 10.3389/fphys.2020.00468. eCollection 2020.
8
Cardiac Energetics in Patients With Aortic Stenosis and Preserved Versus Reduced Ejection Fraction.主动脉瓣狭窄伴射血分数保留与降低患者的心脏能量学。
Circulation. 2020 Jun 16;141(24):1971-1985. doi: 10.1161/CIRCULATIONAHA.119.043450. Epub 2020 May 22.
9
Myocardial Contractility: Historical and Contemporary Considerations.心肌收缩力:历史与当代思考
Front Physiol. 2020 Mar 31;11:222. doi: 10.3389/fphys.2020.00222. eCollection 2020.
10
Critical examination of mechanisms underlying the reduction in heart failure events with SGLT2 inhibitors: identification of a molecular link between their actions to stimulate erythrocytosis and to alleviate cellular stress.对钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂降低心力衰竭事件发生风险的潜在机制进行批判性审视:确定其刺激红细胞增多作用与减轻细胞应激作用之间的分子联系。
Cardiovasc Res. 2021 Jan 1;117(1):74-84. doi: 10.1093/cvr/cvaa064.